- Home
- SRFM vs PYPD Comparison
SRFM vs PYPD Comparison
Compare SRFM & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- PYPD
- Stock Information
- Founded
- SRFM 2011
- PYPD 2008
- Country
- SRFM United States
- PYPD Israel
- Employees
- SRFM N/A
- PYPD N/A
- Industry
- SRFM Transportation Services
- PYPD Medical/Dental Instruments
- Sector
- SRFM Consumer Discretionary
- PYPD Health Care
- Exchange
- SRFM Nasdaq
- PYPD Nasdaq
- Market Cap
- SRFM 62.8M
- PYPD 16.5M
- IPO Year
- SRFM 2023
- PYPD 2020
- Fundamental
- Price
- SRFM $3.33
- PYPD $3.22
- Analyst Decision
- SRFM Hold
- PYPD Strong Buy
- Analyst Count
- SRFM 2
- PYPD 2
- Target Price
- SRFM $3.40
- PYPD $12.00
- AVG Volume (30 Days)
- SRFM 604.8K
- PYPD 29.0K
- Earning Date
- SRFM 11-14-2024
- PYPD 02-12-2025
- Dividend Yield
- SRFM N/A
- PYPD N/A
- EPS Growth
- SRFM N/A
- PYPD N/A
- EPS
- SRFM N/A
- PYPD N/A
- Revenue
- SRFM $118,212,000.00
- PYPD N/A
- Revenue This Year
- SRFM $102.41
- PYPD N/A
- Revenue Next Year
- SRFM $47.46
- PYPD N/A
- P/E Ratio
- SRFM N/A
- PYPD N/A
- Revenue Growth
- SRFM 198.78
- PYPD N/A
- 52 Week Low
- SRFM $0.90
- PYPD $2.37
- 52 Week High
- SRFM $11.83
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- SRFM 50.96
- PYPD 53.21
- Support Level
- SRFM $2.76
- PYPD $2.37
- Resistance Level
- SRFM $4.50
- PYPD $3.13
- Average True Range (ATR)
- SRFM 0.81
- PYPD 0.32
- MACD
- SRFM -0.18
- PYPD 0.05
- Stochastic Oscillator
- SRFM 20.92
- PYPD 64.89
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.